Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus

Background: Hydroxychloroquine (HCQ) is an antimalarial agent given to patients with systemic lupus erythematosus (SLE) as first-line therapy. It alleviates childhood-onset systemic lupus erythematosus cSLE skin and musculoskeletal disease, decreasing disease activity and flares. HCQ concentration–e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahr, Noël, Urien, Saik, Funck-Brentano, Christian, Vantomme, Hélène, Garcelon, Nicolas, Melki, Isabelle, Boistault, Margaux, Boyer, Olivia, Bader-Meunier, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002378/
https://www.ncbi.nlm.nih.gov/pubmed/33802811
http://dx.doi.org/10.3390/ph14030273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002378/
https://www.ncbi.nlm.nih.gov/pubmed/33802811
http://dx.doi.org/10.3390/ph14030273

Ejemplares similares